People with a rare genetic form of Alzheimer’s disease can begin…
Category: Therapeutic Areas
Home /
Cruise ships are seeing a surge in norovirus outbreaks this year….
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming…
With millions of tuberculosis (TB) cases left undiagnosed each year due…
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom),…
Eli Lilly has launched a new way for patients to access…
Clinical trial results show that pembrolizumab, an immunotherapy drug used to…
United States agricultural hubs are currently facing an unprecedented outbreak of…
In the early days of the human immunodeficiency virus (HIV) epidemic,…
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in…
The Danish pharmaceutical company Novo Nordisk has announced promising early results…
Death rates for cancer are lower than ever, having declined as…
The relationship between cancer and the nervous system has been a…
NodThera, a biotech company based in Cambridge, England, is developing a…
Annual flu shots in the United States are going to be…
As GLP-1 receptor agonist injections continue to gain acceptance as effective…
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur…
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in…
For decades, the battle against autoimmune diseases like type 1 diabetes,…
Research using data from a large U.S. health survey has disrupted…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
Webinars
Slowing the Clock: Trial Delivers Hope in Delaying Alzheimer’s Disease
April 7, 2025
People with a rare genetic form of Alzheimer’s disease can begin to experience memory loss and dementia starting in their 30s, 40s and 50s. Although
Rough Seas: Norovirus Outbreaks Surge on Cruise Ships and Beyond
March 17, 2025
Cruise ships are seeing a surge in norovirus outbreaks this year. The Centers for Disease Control and Prevention (CDC), which publishes details of the outbreaks
Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
November 18, 2024
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and strips
Sounding Out Disease: Using AI to Help Close the Diagnosis Gap for Millions with Tuberculosis
November 11, 2024
With millions of tuberculosis (TB) cases left undiagnosed each year due to limited healthcare access or incorrect diagnoses, researchers are turning to artificial intelligence (AI)
Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
November 4, 2024
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to advanced
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials at
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal cancer
Experts Assess Risk of Avian Flu to Humans
July 29, 2024
United States agricultural hubs are currently facing an unprecedented outbreak of the H5N1 virus, more commonly known as the avian flu or “bird flu.” As
Mapping the Evolution of HIV Treatment and the Path to a Cure
July 24, 2024
In the early days of the human immunodeficiency virus (HIV) epidemic, there was little hope. HIV infection, when untreated, damages the immune system, making people
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk of
Novo Nordisk Offers a New Contender in Weight Management — in Pill Form
May 20, 2024
The Danish pharmaceutical company Novo Nordisk has announced promising early results for amycretin, a novel oral weight loss medication. This new drug appears to outperform
Oncology Drug Development: The Current State of Affairs
April 29, 2024
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in oncology
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the early
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
April 15, 2024
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein 3
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
April 8, 2024
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually included
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani Medical
Psychoactive Drug Ibogaine Has Transformative Effects for Veterans with Traumatic Brain Injury
March 11, 2024
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur deep damage and invisible scars. Such injuries are significant contributors to post-traumatic stress disorder
The Link Between Obesity Drugs and Brain Health
March 6, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic, Wegovy,
Advances in Treating Autoimmune Diseases Focus on Restoring Immune Tolerance
March 4, 2024
For decades, the battle against autoimmune diseases like type 1 diabetes, lupus, and multiple sclerosis has been an uphill struggle. Conventional treatments most often alleviate
Research Challenges Conventional Wisdom on Obesity and Mortality
February 26, 2024
Research using data from a large U.S. health survey has disrupted conventional thinking about body mass index (BMI) and its role in predicting all-cause mortality.
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
